James B. Smith

Part of Becton, Dickinson & Co., PharMingen is a company that manufactures antibodies and reagents for biological research. The company is based in San Diego, CA. PharMingen was acquired by Becton, Dickinson & Co. on May 19, 1997.

Diagnomics, Inc. engages in the research and development of personalized advanced healthcare services. It offers consumer genomics solutions, analysis platform, clinical and translational research, assay development support, and bioinformatics services. The company was founded by Min Seob Lee, Stefan Gruenwald, and Dan Scholefield in 2011 and is headquartered in San Diego, CA.

Financial Industry Regulatory Authority, Inc. engages in the provision of securities regulation, complementary compliance, and technology-based services. Its services include writing and enforcing rules governing the activities of securities firms with brokers, examining firms for compliance with those rules, fostering market transparency, and educating investors. The company was founded in 2007 and is headquartered in Washington, DC.

The Securities Investor Protection Corporation either acts as trustee or works with an independent court-appointed trustee in a missing asset case to recover funds. The statute that created SIPC provides that customers of a failed brokerage firm receive all non-negotiable securities that are already registered in their names or in the process of being registered. Recovered funds are used to replenish SIPC's reserve in the event that the reserve is tapped in the early stages of a liquidation proceeding.

Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA.